BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 12952927)

  • 1. Secreted frizzled-related protein 4 is a potent tumor-derived phosphaturic agent.
    Berndt T; Craig TA; Bowe AE; Vassiliadis J; Reczek D; Finnegan R; Jan De Beur SM; Schiavi SC; Kumar R
    J Clin Invest; 2003 Sep; 112(5):785-94. PubMed ID: 12952927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor induced osteomalacia: associated with elevated circulating levels of fibroblast growth factor-7 in addition to fibroblast growth factor-23.
    Bansal S; Khazim K; Suri R; Martin D; Werner S; Fanti P
    Clin Nephrol; 2016 Jan; 85(1):57-62. PubMed ID: 26521888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of FN1-FGFR1 and novel FN1-FGF1 fusion genes in a large series of phosphaturic mesenchymal tumors.
    Lee JC; Su SY; Changou CA; Yang RS; Tsai KS; Collins MT; Orwoll ES; Lin CY; Chen SH; Shih SR; Lee CH; Oda Y; Billings SD; Li CF; Nielsen GP; Konishi E; Petersson F; Carpenter TO; Sittampalam K; Huang HY; Folpe AL
    Mod Pathol; 2016 Nov; 29(11):1335-1346. PubMed ID: 27443518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism.
    Shimada T; Kakitani M; Yamazaki Y; Hasegawa H; Takeuchi Y; Fujita T; Fukumoto S; Tomizuka K; Yamashita T
    J Clin Invest; 2004 Feb; 113(4):561-8. PubMed ID: 14966565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Missed causative tumors in diagnosing tumor-induced osteomalacia with (18)F-FDG PET/CT: a potential pitfall of standard-field imaging.
    Kaneuchi Y; Hakozaki M; Yamada H; Hasegawa O; Tajino T; Konno S
    Hell J Nucl Med; 2016; 19(1):46-8. PubMed ID: 26929940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of 18F-FDG and 68Ga DOTATATE PET/CT in localization of tumor causing oncogenic osteomalacia.
    Agrawal K; Bhadada S; Mittal BR; Shukla J; Sood A; Bhattacharya A; Bhansali A
    Clin Nucl Med; 2015 Jan; 40(1):e6-e10. PubMed ID: 24999675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized trial of the anti-FGF23 antibody KRN23 in X-linked hypophosphatemia.
    Carpenter TO; Imel EA; Ruppe MD; Weber TJ; Klausner MA; Wooddell MM; Kawakami T; Ito T; Zhang X; Humphrey J; Insogna KL; Peacock M
    J Clin Invest; 2014 Apr; 124(4):1587-97. PubMed ID: 24569459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical impact of somatostatin receptor scintigraphy in the management of tumor-induced osteomalacia.
    Duet M; Kerkeni S; Sfar R; Bazille C; Lioté F; Orcel P
    Clin Nucl Med; 2008 Nov; 33(11):752-6. PubMed ID: 18936605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cinacalcet in the management of tumor-induced osteomalacia.
    Geller JL; Khosravi A; Kelly MH; Riminucci M; Adams JS; Collins MT
    J Bone Miner Res; 2007 Jun; 22(6):931-7. PubMed ID: 17352646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of a mesenchymal tumor responsible for hypophosphatemic osteomalacia using FDG-PET.
    Dupond JL; Mahammedi H; Magy N; Blagosklonov O; Meaux-Ruault N; Kantelip B
    Eur J Intern Med; 2005 Oct; 16(6):445-6. PubMed ID: 16198908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 68Ga-DOTANOC: a first compound for PET imaging with high affinity for somatostatin receptor subtypes 2 and 5.
    Wild D; Mäcke HR; Waser B; Reubi JC; Ginj M; Rasch H; Müller-Brand J; Hofmann M
    Eur J Nucl Med Mol Imaging; 2005 Jun; 32(6):724. PubMed ID: 15551131
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment for lupus nephritis: an overview of systematic reviews and meta-analyses.
    Chen Y; Sun J; Zou K; Yang Y; Liu G
    Rheumatol Int; 2017 Jul; 37(7):1089-1099. PubMed ID: 28493175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Daily Self-Weighing to Control Body Weight in Adults: A Critical Review of the Literature.
    Pacanowski CR; Bertz FC; Levitsky DA
    Sage Open; 2014; 4(4):1-16. PubMed ID: 27127719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Possibility of D2-40 as a diagnostic and tumor differentiation-suggestive marker for some of phosphaturic mesenchymal tumors.
    Tajima S; Fukayama M
    Int J Clin Exp Pathol; 2015; 8(8):9390-6. PubMed ID: 26464693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An official European Respiratory Society/American Thoracic Society research statement: interstitial pneumonia with autoimmune features.
    Fischer A; Antoniou KM; Brown KK; Cadranel J; Corte TJ; du Bois RM; Lee JS; Leslie KO; Lynch DA; Matteson EL; Mosca M; Noth I; Richeldi L; Strek ME; Swigris JJ; Wells AU; West SG; Collard HR; Cottin V;
    Eur Respir J; 2015 Oct; 46(4):976-87. PubMed ID: 26160873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TGF-β and SMADs mRNA Expression in Pulmonary Sarcoidosis.
    Piotrowski WJ; Kiszałkiewicz J; Pastuszak-Lewandoska D; Antczak A; Górski P; Migdalska-Sęk M; Górski W; Czarnecka K; Nawrot E; Domańska D; Brzeziańska-Lasota E
    Adv Exp Med Biol; 2015; 852():59-69. PubMed ID: 25753554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogenesis of macrophage activation syndrome and potential for cytokine- directed therapies.
    Schulert GS; Grom AA
    Annu Rev Med; 2015; 66():145-59. PubMed ID: 25386930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 68Ga DOTA-TATE PET/CT allows tumor localization in patients with tumor-induced osteomalacia but negative 111In-octreotide SPECT/CT.
    Breer S; Brunkhorst T; Beil FT; Peldschus K; Heiland M; Klutmann S; Barvencik F; Zustin J; Gratz KF; Amling M
    Bone; 2014 Jul; 64():222-7. PubMed ID: 24769333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic sclerosis with sarcoidosis: case report and review of the published work.
    Senda S; Igawa K; Nishioka M; Murota H; Katayama I
    J Dermatol; 2014 May; 41(5):421-3. PubMed ID: 24617417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society.
    Jensen MD; Ryan DH; Apovian CM; Ard JD; Comuzzie AG; Donato KA; Hu FB; Hubbard VS; Jakicic JM; Kushner RF; Loria CM; Millen BE; Nonas CA; Pi-Sunyer FX; Stevens J; Stevens VJ; Wadden TA; Wolfe BM; Yanovski SZ; Jordan HS; Kendall KA; Lux LJ; Mentor-Marcel R; Morgan LC; Trisolini MG; Wnek J; Anderson JL; Halperin JL; Albert NM; Bozkurt B; Brindis RG; Curtis LH; DeMets D; Hochman JS; Kovacs RJ; Ohman EM; Pressler SJ; Sellke FW; Shen WK; Smith SC; Tomaselli GF; ;
    Circulation; 2014 Jun; 129(25 Suppl 2):S102-38. PubMed ID: 24222017
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.